Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project

Boada, Mercè; Rodrigo, Adrián; Jessen, Frank; Wimblad, Bengt; Kramberger, Milika; Visser, Pieter Jelle; Simó Canonge, Rafael; Ciudin Mihai, Andreea

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Boada, Mercè
dc.contributor.author	Rodrigo, Adrián
dc.contributor.author	Jessen, Frank
dc.contributor.author	Wimblad, Bengt
dc.contributor.author	Kramberger, Milika
dc.contributor.author	Visser, Pieter Jelle
dc.contributor.author	Simó Canonge, Rafael
dc.contributor.author	Ciudin Mihai, Andreea
dc.date.accessioned	2022-06-27T11:55:05Z
dc.date.available	2022-06-27T11:55:05Z
dc.date.issued	2022-06
dc.identifier.citation	Boada M, Rodrigo A, Jessen F, Wimblad B, Kramberger M, Visser PJ, et al. Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer’s disease: Results from the MOPEAD project. Alzheimers Dement. 2022 Jun;18(6):1119–27.
dc.identifier.issn	1552-5279
dc.identifier.uri	https://hdl.handle.net/11351/7729
dc.description	Brecha de diagnóstico; Diagnóstico precoz; Población
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartofseries	Alzheimer's & Dementia;18(6)
dc.rights	Attribution-NonCommercial 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/
dc.source	Scientia
dc.subject	Alzheimer, Malaltia d' - Diagnòstic
dc.subject	Pacients - Participació
dc.subject	Cribatge (Medicina)
dc.subject.mesh	Alzheimer Disease
dc.subject.mesh	/diagnosis
dc.subject.mesh	Patient Participation
dc.subject.mesh	Mass Screening
dc.title	Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1002/alz.12441
dc.subject.decs	enfermedad de Alzheimer
dc.subject.decs	/diagnóstico
dc.subject.decs	participación del paciente
dc.subject.decs	cribado sistemático
dc.relation.publishversion	https://doi.org/10.1002/alz.12441
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Boada M] Research Center and Memory Clinic, Fundació ACEInstitut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain. Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain. [Rodrigo A] GMV SECURE E SOLUTIONS, Valencia, Spain. [Jessen F] Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, Cologne, Germany. [Wimblad B] Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden. Theme Aging, Karolinska Univ Hospital, Stockholm, Sweden. [Kramberger M] Center for Cognitive Impairments, Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia. [Visser PJ] Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit AmsterdamAmsterdam UMC, Amsterdam, the Netherlands. Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands. [Simó R, Ciudin A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain
dc.identifier.pmid	34310061
dc.identifier.wos	000680909100001
dc.rights.accessrights	info:eu-repo/semantics/openAccess